Baillie Gifford - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,336
-59.4%
3,7110.0%0.00%
Q4 2022$3,288
-45.2%
3,7110.0%0.00%
Q3 2022$6,000
-33.3%
3,711
-14.0%
0.00%
Q2 2022$9,000
-10.0%
4,3140.0%0.00%
Q1 2022$10,000
-50.0%
4,3140.0%0.00%
Q4 2021$20,000
-39.4%
4,3140.0%0.00%
Q3 2021$33,000
-34.0%
4,314
-16.3%
0.00%
Q2 2021$50,000
+8.7%
5,152
-6.9%
0.00%
Q1 2021$46,000
+31.4%
5,531
+8.3%
0.00%
Q4 2020$35,0005,1090.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders